A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
Abroad (travel likely)Recruiting
Conditions
Myasthenia Gravis · CIDP - Chronic Inflammatory Demyelinating Polyneuropathy
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
United BioSource LLC, Morgantown, West Virginia, United States
Klinikum der Ruhr-Universität Bochum St. Josef Hospital Neurologische Interdisziplinäre Infusionsambulanz + MS Studienambulanz (Haus E Ebene1), Bochum, Germany
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy
Hospital Universitari Vall d'Hebron, Barcelona, Spain